HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annette K Larsen Selected Research

hyalodendrin

4/2020Secondary Metabolites from the Culture of the Marine-derived Fungus Paradendryphiella salina PC 362H and Evaluation of the Anticancer Activity of Its Metabolite Hyalodendrin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Annette K Larsen Research Topics

Disease

51Neoplasms (Cancer)
01/2022 - 01/2003
26Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2005
14Colonic Neoplasms (Colon Cancer)
05/2013 - 10/2004
7Carcinoma (Carcinomatosis)
12/2017 - 01/2002
6Ovarian Neoplasms (Ovarian Cancer)
07/2021 - 04/2006
6Breast Neoplasms (Breast Cancer)
07/2021 - 08/2005
5Thrombophilia
11/2018 - 01/2017
4Microsatellite Instability
01/2014 - 05/2007
3Carcinogenesis
12/2019 - 01/2016
3Disease Progression
12/2019 - 11/2015
3Pancreatic Neoplasms (Pancreatic Cancer)
02/2019 - 01/2016
3Adenocarcinoma
03/2017 - 05/2009
3Sarcoma (Soft Tissue Sarcoma)
05/2016 - 07/2003
3Hypoxia (Hypoxemia)
07/2014 - 02/2009
2Endometrial Neoplasms (Endometrial Cancer)
03/2021 - 06/2019
2Melanoma (Melanoma, Malignant)
12/2020 - 12/2019
2Multiple Myeloma
10/2019 - 11/2018
2Thrombosis (Thrombus)
11/2018 - 10/2018
2Venous Thromboembolism
11/2018 - 10/2017
2Ataxia Telangiectasia (Louis Bar Syndrome)
05/2016 - 07/2011
2Chromosomal Instability (Chromosome Stability)
01/2014 - 05/2013
2Stomach Neoplasms (Stomach Cancer)
01/2013 - 08/2005
2Leukemia
09/2005 - 07/2003
2Prostatic Neoplasms (Prostate Cancer)
08/2004 - 07/2003
1Anemia
01/2020
1Bone Diseases (Bone Disease)
10/2019
1Infections
02/2019
1Chronic Kidney Failure (Chronic Renal Failure)
02/2019
1Liver Abscess
02/2019
1Cystic Fibrosis (Mucoviscidosis)
02/2019
1Hypertension (High Blood Pressure)
01/2019
1Adenocarcinoma of Lung
11/2018

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2010
10Pharmaceutical PreparationsIBA
01/2018 - 08/2005
9Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 08/2005
9Fluorouracil (Carac)FDA LinkGeneric
09/2018 - 11/2003
9Bevacizumab (Avastin)FDA Link
01/2018 - 12/2006
8Cetuximab (Erbitux)FDA Link
01/2018 - 12/2006
7Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2004
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 04/2006
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 01/2007
6ThrombinFDA Link
11/2018 - 03/2017
6Cisplatin (Platino)FDA LinkGeneric
05/2016 - 07/2003
6DNA (Deoxyribonucleic Acid)IBA
10/2013 - 01/2002
5ErbB Receptors (EGF Receptor)IBA
01/2020 - 12/2006
5Leucovorin (Folinic Acid)FDA Link
01/2019 - 12/2006
5Monoclonal AntibodiesIBA
01/2018 - 01/2007
5TrabectedinIBA
05/2016 - 07/2003
4Biological ProductsIBA
02/2019 - 07/2011
4Phospholipids (Phosphatides)FDA LinkGeneric
11/2018 - 12/2017
4PlatinumIBA
05/2016 - 12/2013
4irofulvenIBA
04/2006 - 07/2003
3MicroRNAs (MicroRNA)IBA
03/2021 - 01/2019
3CytokinesIBA
12/2019 - 04/2016
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 11/2015
31,2- diacetoxy- 3,14- dihydro- 3,3,14- trimethyl- 6- methoxy- 7H- benz(b)pyrano(3,2- d)acridin- 7- oneIBA
01/2015 - 08/2010
3Alkylating AgentsIBA
10/2013 - 08/2004
2OsteopontinIBA
01/2022 - 07/2021
2Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2009
2Formaldehyde (Formol)FDA Link
06/2019 - 10/2016
2ParaffinIBA
06/2019 - 10/2016
2afliberceptIBA
01/2019 - 09/2018
2Tyrosine Kinase InhibitorsIBA
01/2018 - 11/2015
2Thromboplastin (Tissue Factor)IBA
12/2017 - 12/2017
2AfatinibIBA
01/2016 - 10/2011
2Phosphotransferases (Kinase)IBA
01/2016 - 07/2011
2nintedanibIBA
07/2014 - 10/2011
2EnzymesIBA
05/2013 - 07/2003
2Antineoplastic Agents (Antineoplastics)IBA
05/2013 - 10/2012
2Topoisomerase I InhibitorsIBA
01/2013 - 08/2005
27-hydroxystaurosporine (UCN 01)IBA
09/2007 - 01/2002
1Purinergic Receptors (Receptors, Purine)IBA
10/2021
1Adenosine Triphosphate (ATP)IBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1Adenosine (Adenocard)FDA LinkGeneric
10/2021
1PhosphoproteinsIBA
07/2021
1ChromatinIBA
03/2021
1Histones (Histone)IBA
03/2021
1Interleukin-4 (Interleukin 4)IBA
12/2020
1hyalodendrinIBA
04/2020
1MycotoxinsIBA
04/2020
1Complex MixturesIBA
04/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020
1Alkaline PhosphataseIBA
01/2020
1Interleukin-18 (Interleukin 18)IBA
12/2019
1Interleukin-2 (IL2)IBA
12/2019
1Interleukin-12 (IL 12)IBA
12/2019
1Antiviral Agents (Antivirals)IBA
12/2019
1AntigensIBA
02/2019
1Anti-Bacterial Agents (Antibiotics)IBA
02/2019
1CarbohydratesIBA
02/2019
1Tumor Biomarkers (Tumor Markers)IBA
02/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
11/2018

Therapy/Procedure

21Therapeutics
01/2019 - 08/2003
10Drug Therapy (Chemotherapy)
04/2020 - 12/2009
6Adjuvant Chemotherapy
08/2011 - 01/2007
2Radiotherapy
01/2019 - 01/2016
1Liver Transplantation
02/2019